Phibro Animal Health (NASDAQ:PAHC) Sets New 12-Month High at $17.42

Phibro Animal Health Co. (NASDAQ:PAHC)’s share price reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $17.42 and last traded at $17.36, with a volume of 47998 shares changing hands. The stock had previously closed at $16.77.

Wall Street Analyst Weigh In

Separately, StockNews.com raised Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Tuesday, April 9th.

Phibro Animal Health Price Performance

The company has a market capitalization of $695.79 million, a price-to-earnings ratio of 46.58, a price-to-earnings-growth ratio of 6.30 and a beta of 0.63. The company has a 50-day moving average price of $13.39 and a 200-day moving average price of $12.00. The company has a debt-to-equity ratio of 1.66, a quick ratio of 1.60 and a current ratio of 3.12.

Phibro Animal Health (NASDAQ:PAHC) last posted its earnings results on Wednesday, February 7th. The company reported $0.33 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.06. Phibro Animal Health had a net margin of 1.51% and a return on equity of 16.67%. The company had revenue of $249.90 million for the quarter, compared to analyst estimates of $242.91 million. On average, equities research analysts expect that Phibro Animal Health Co. will post 1.12 EPS for the current fiscal year.

Institutional Investors Weigh In On Phibro Animal Health

Several large investors have recently modified their holdings of the business. Barclays PLC increased its stake in Phibro Animal Health by 59.8% during the 3rd quarter. Barclays PLC now owns 35,638 shares of the company’s stock worth $456,000 after purchasing an additional 13,332 shares in the last quarter. Trexquant Investment LP lifted its position in Phibro Animal Health by 143.6% in the 3rd quarter. Trexquant Investment LP now owns 35,872 shares of the company’s stock valued at $458,000 after acquiring an additional 21,147 shares in the last quarter. Brandes Investment Partners LP boosted its stake in Phibro Animal Health by 38.5% in the 3rd quarter. Brandes Investment Partners LP now owns 1,873,300 shares of the company’s stock worth $23,922,000 after purchasing an additional 520,697 shares during the period. China Universal Asset Management Co. Ltd. increased its holdings in Phibro Animal Health by 358.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 2,357 shares of the company’s stock worth $27,000 after purchasing an additional 1,843 shares in the last quarter. Finally, New York State Common Retirement Fund lifted its holdings in shares of Phibro Animal Health by 20.9% in the third quarter. New York State Common Retirement Fund now owns 69,944 shares of the company’s stock valued at $893,000 after purchasing an additional 12,110 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.